Chronic hemodialysis therapy is a well-recognized supportive therapy for patients with end-stage kidney disease. However, this therapy is poorly implemented in low-income countries due to its high cost. We herein report a single-center experience in one of the poorest countries in the world, i.e., Niger.
DIONGOLE et al. (Wed,) studied this question.